EE200300018A - Parapoxvirus ovis tüvede kasutamine viirusvastaste ja vähivastaste ravimite valmistamiseks - Google Patents
Parapoxvirus ovis tüvede kasutamine viirusvastaste ja vähivastaste ravimite valmistamiseksInfo
- Publication number
- EE200300018A EE200300018A EEP200300018A EEP200300018A EE200300018A EE 200300018 A EE200300018 A EE 200300018A EE P200300018 A EEP200300018 A EE P200300018A EE P200300018 A EEP200300018 A EE P200300018A EE 200300018 A EE200300018 A EE 200300018A
- Authority
- EE
- Estonia
- Prior art keywords
- antiviral
- manufacture
- anticancer drugs
- parapoxvirus ovis
- strains
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24211—Parapoxvirus, e.g. Orf virus
- C12N2710/24232—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Diabetes (AREA)
- Ophthalmology & Optometry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Surgery (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10033582 | 2000-07-11 | ||
DE10122451A DE10122451A1 (de) | 2000-07-11 | 2001-05-09 | Verwendung von Stämmen des Parapoxvirus ovis zur Herstellung von antiviralen Arzneimitteln und Arzneimitteln gegen Krebs |
PCT/EP2001/007991 WO2002004002A2 (fr) | 2000-07-11 | 2001-07-11 | Utilisation de souches du virus parapox ovis pour la fabrication de medicaments antiviraux et anticancereux |
Publications (1)
Publication Number | Publication Date |
---|---|
EE200300018A true EE200300018A (et) | 2004-10-15 |
Family
ID=26006335
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP200300018A EE200300018A (et) | 2000-07-11 | 2001-07-11 | Parapoxvirus ovis tüvede kasutamine viirusvastaste ja vähivastaste ravimite valmistamiseks |
Country Status (36)
Country | Link |
---|---|
US (1) | US6685950B2 (fr) |
EP (1) | EP1303286B1 (fr) |
JP (1) | JP5037775B2 (fr) |
CN (1) | CN1455674B (fr) |
AR (1) | AR029954A1 (fr) |
AT (1) | ATE324115T1 (fr) |
AU (2) | AU2001270631B2 (fr) |
BG (1) | BG107448A (fr) |
CA (1) | CA2415397C (fr) |
CY (1) | CY1105408T1 (fr) |
CZ (1) | CZ200371A3 (fr) |
DE (1) | DE50109630D1 (fr) |
DK (2) | DK1303286T3 (fr) |
EE (1) | EE200300018A (fr) |
ES (1) | ES2262663T3 (fr) |
FI (1) | FI20030037A (fr) |
GB (1) | GB2381454B8 (fr) |
HK (1) | HK1054329B (fr) |
HR (1) | HRP20030096A2 (fr) |
HU (1) | HUP0400479A3 (fr) |
IL (1) | IL153643A0 (fr) |
LT (1) | LT5079B (fr) |
LU (1) | LU90997B1 (fr) |
LV (1) | LV12990B (fr) |
MA (1) | MA26927A1 (fr) |
MX (1) | MXPA03000279A (fr) |
NO (1) | NO20030082D0 (fr) |
NZ (1) | NZ523534A (fr) |
PL (1) | PL366397A1 (fr) |
PT (1) | PT1303286E (fr) |
RU (1) | RU2003104525A (fr) |
SE (1) | SE0300034L (fr) |
SI (1) | SI21122A (fr) |
SK (1) | SK362003A3 (fr) |
UY (1) | UY26832A1 (fr) |
WO (1) | WO2002004002A2 (fr) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19922407A1 (de) * | 1999-05-14 | 2000-11-16 | Bayer Ag | Organ-, gewebs- und zellspezifisches Immuntherapeutikum für chronische virale Infektionen, sowie entzündliche, degenerative und proliferative Erkrankungen insbesondere der Leber sowie Krebs auf der Basis von rekombinantem Parapoxvirus |
US7097842B2 (en) * | 2000-11-23 | 2006-08-29 | Bavarian Nordic A/S | Modified vaccinia virus ankara for the vaccination of neonates |
EE05680B1 (et) | 2000-11-23 | 2013-10-15 | Bavarian Nordic A/S | Muundatud vaktsiiniaviirus, selle valmistamine ja kasutamine, seda sisaldav farmatseutiline kompositsioon ning vaktsiin |
WO2004022729A1 (fr) * | 2002-09-05 | 2004-03-18 | Bavarian Nordic A/S | Technique de culture de cellules primaires et d'amplification de virus dans un environnement exempt de serum |
US7628980B2 (en) * | 2000-11-23 | 2009-12-08 | Bavarian Nordic A/S | Modified vaccinia virus ankara for the vaccination of neonates |
NZ512341A (en) | 2001-06-13 | 2004-02-27 | Bayer Ag | Polynucleotides between 15 and 100 base pairs in length coding for parapoxvirus ovis (PPVO)/vaccinia virus recombinant (VVOV) viral genome fragments |
AU2002362072A1 (en) * | 2001-12-07 | 2003-06-23 | Board Of Regents The University Of Texas System | Use a parapox b2l protein to modify immune responses to administered antigens |
AU2003239805B2 (en) * | 2002-04-19 | 2009-09-10 | Bavarian Nordic A/S | Modified vaccinia virus ankara for the vaccination of neonates |
PL1765370T3 (pl) * | 2004-07-13 | 2010-02-26 | Aicuris Gmbh & Co Kg | Parapoksywirusy w kombinacji z innymi czynnikami przeciwwirusowymi do leczenia HIV/AIDS |
DE602006010902D1 (de) * | 2005-11-24 | 2010-01-14 | Aicuris Gmbh & Co Kg | Parapocken-viren in kombination mit klassischen zytotoxischen chemotherapeutika als biochemotherapie zur behandlung von krebs |
JP5004990B2 (ja) * | 2009-03-31 | 2012-08-22 | アイキュリス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング・ウント・コムパニー・コマンディットゲゼルシャフト | パラポックスウイルス・オヴィスの組換えタンパク質およびそれ由来の医薬組成物 |
US9090897B2 (en) * | 2009-12-18 | 2015-07-28 | Bavarian Nordic A/S | Production of IFN-lambda by conventional dendritic cells |
JP5699093B2 (ja) * | 2012-01-05 | 2015-04-08 | アイキュリス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング・ウント・コムパニー・コマンディットゲゼルシャフトAiCuris GmbH & Co. KG | パラポックスウイルス・オヴィスの組換えタンパク質およびそれ由来の医薬組成物 |
TW201919675A (zh) * | 2017-09-07 | 2019-06-01 | 德商艾庫瑞斯公司 | 使用羊副痘疹病毒(Parapoxvirus ovis;PPVO)及至少一種額外抗病毒藥之經B型肝炎病毒(HBV)感染之個體之組合療法 |
WO2023083943A1 (fr) * | 2021-11-10 | 2023-05-19 | Aicuris Gmbh & Co. Kg | Parapoxvirus pour la préparation à des infections virales respiratoires et le traitement de telles infections en combinaison avec des antiviraux |
WO2023083950A1 (fr) * | 2021-11-10 | 2023-05-19 | Aicuris Gmbh & Co. Kg | Parapoxvirus pour la préparation à des infections virales respiratoires et le traitement de telles infections en combinaison avec des immunomodulateurs |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2714665A1 (de) * | 1977-04-01 | 1978-10-05 | Mayr Anton | Praeparat zur behandlung von herpes zoster und anderen herpes-infektionen, sowie verfahren zu seiner herstellung |
DE3504940C2 (de) * | 1984-02-17 | 1997-11-06 | Bayer Ag | Multipotente Paramunitätsmediatoren, Verfahren zu ihrer Herstellung und diese Mediatoren enthaltende Arzneimittel |
US5443964A (en) * | 1987-08-10 | 1995-08-22 | Duke University | Poxvirus insertion/expression vector |
DE4405841C1 (de) * | 1994-02-23 | 1995-01-05 | Mayr Anton Prof Dr Med Vet Dr | Multipotente Paramunitätsinducer auf der Basis von Kombinationen von Pockenviruskomponenten, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
US5648101A (en) * | 1994-11-14 | 1997-07-15 | Tawashi; Rashad | Drug delivery of nitric oxide |
DE59712852D1 (de) * | 1996-02-28 | 2007-07-19 | Bayer Healthcare Ag | Parapockenviren, die fremd-dna enthalten, ihre herstellung und ihre verwendung in impfstoffen |
HUP9902438A3 (en) * | 1996-03-29 | 2000-03-28 | Bayer Ag | Parapoxvirus vectors |
HU224308B1 (hu) * | 1996-04-15 | 2005-07-28 | Anton Mayr | Attenuált, nem immunogén poxvírusokból vagy parapoxvírusokból származó multipotens parapox immunitás-inducerek alkalmazása gyógyszerkészítmények előállítására |
SE9700617D0 (sv) * | 1997-02-21 | 1997-02-21 | Kjell Alving | New composition |
DE19843222A1 (de) * | 1998-09-22 | 2000-03-30 | Hassan Jomaa | Verwendung von phosphororganischen Verbindungen zur therapeutischen und prophylaktischen Behandlung von Infektionen |
JP2003517275A (ja) * | 1998-11-02 | 2003-05-27 | ルードヴィッヒ インスティテュート フォー キャンサー リサーチ | 哺乳動物vegfレセプター−2に結合し、これを活性化するオルフウイルスnz2由来の血管内皮細胞増殖因子様タンパク質 |
-
2001
- 2001-07-11 EP EP01949489A patent/EP1303286B1/fr not_active Expired - Lifetime
- 2001-07-11 PL PL01366397A patent/PL366397A1/xx not_active Application Discontinuation
- 2001-07-11 MX MXPA03000279A patent/MXPA03000279A/es unknown
- 2001-07-11 HU HU0400479A patent/HUP0400479A3/hu unknown
- 2001-07-11 ES ES01949489T patent/ES2262663T3/es not_active Expired - Lifetime
- 2001-07-11 JP JP2002508456A patent/JP5037775B2/ja not_active Expired - Lifetime
- 2001-07-11 RU RU2003104525/15A patent/RU2003104525A/ru not_active Application Discontinuation
- 2001-07-11 WO PCT/EP2001/007991 patent/WO2002004002A2/fr active IP Right Grant
- 2001-07-11 AT AT01949489T patent/ATE324115T1/de active
- 2001-07-11 SK SK36-2003A patent/SK362003A3/sk not_active Application Discontinuation
- 2001-07-11 EE EEP200300018A patent/EE200300018A/xx unknown
- 2001-07-11 SI SI200120048A patent/SI21122A/sl not_active IP Right Cessation
- 2001-07-11 LU LU90997A patent/LU90997B1/en active
- 2001-07-11 US US09/903,013 patent/US6685950B2/en not_active Expired - Lifetime
- 2001-07-11 PT PT01949489T patent/PT1303286E/pt unknown
- 2001-07-11 AU AU2001270631A patent/AU2001270631B2/en not_active Expired - Fee Related
- 2001-07-11 GB GB0302630A patent/GB2381454B8/en not_active Expired - Fee Related
- 2001-07-11 CN CN01812685.5A patent/CN1455674B/zh not_active Expired - Lifetime
- 2001-07-11 CA CA2415397A patent/CA2415397C/fr not_active Expired - Lifetime
- 2001-07-11 DK DK01949489T patent/DK1303286T3/da active
- 2001-07-11 AU AU7063101A patent/AU7063101A/xx active Pending
- 2001-07-11 NZ NZ523534A patent/NZ523534A/en not_active IP Right Cessation
- 2001-07-11 UY UY26832A patent/UY26832A1/es not_active Application Discontinuation
- 2001-07-11 CZ CZ200371A patent/CZ200371A3/cs unknown
- 2001-07-11 IL IL15364301A patent/IL153643A0/xx active IP Right Grant
- 2001-07-11 DE DE50109630T patent/DE50109630D1/de not_active Expired - Lifetime
- 2001-07-11 AR ARP010103292A patent/AR029954A1/es unknown
-
2003
- 2003-01-08 BG BG107448A patent/BG107448A/bg unknown
- 2003-01-08 NO NO20030082A patent/NO20030082D0/no unknown
- 2003-01-10 SE SE0300034A patent/SE0300034L/xx not_active Application Discontinuation
- 2003-01-10 DK DK200300015A patent/DK200300015A/da not_active Application Discontinuation
- 2003-01-10 FI FI20030037A patent/FI20030037A/fi not_active IP Right Cessation
- 2003-01-10 MA MA26994A patent/MA26927A1/fr unknown
- 2003-02-03 LT LT2003009A patent/LT5079B/lt not_active IP Right Cessation
- 2003-02-10 HR HR20030096A patent/HRP20030096A2/xx not_active Application Discontinuation
- 2003-02-11 LV LVP-03-14A patent/LV12990B/lv unknown
- 2003-09-15 HK HK03106613.1A patent/HK1054329B/zh not_active IP Right Cessation
-
2006
- 2006-07-24 CY CY20061101024T patent/CY1105408T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE200300018A (et) | Parapoxvirus ovis tüvede kasutamine viirusvastaste ja vähivastaste ravimite valmistamiseks | |
EE05643B1 (et) | Ksantiini derivaadid, nende valmistamine ja kasutamine ravimina | |
EE200200607A (et) | 2-atsüülindoolderivaadid ja nende kasutamine kasvajavastaste ravimitena | |
EE200100413A (et) | Sünteetilised pindaktiivsed peptiidid ja nende kasutamine sünteetilise surfaktandi valmistamiseks | |
EE200300529A (et) | Antraniilhappe amiidid, nende kasutamine ja farmatseutiline preparaat | |
EE200300145A (et) | Asa- ja polüasanaftalenüülkarboksamiidid ja farmatseutiline kompositsioon | |
EE200300193A (et) | Asendatud bensimidasoolid, nende kasutamine ja ravim | |
NO20034159L (no) | Östrogen-gestagen-kombinasjonspreparat og anvendelse derav | |
HUP0203249A3 (en) | Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders | |
EE200200271A (et) | Ravimkombinatsioonid ning nende kasutamine | |
AU2001270631A2 (en) | Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals | |
AU2001270631A1 (en) | Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals | |
NZ523535A (en) | Use of strains of the Parapoxvirus ovis against organ fibroses | |
EE200300454A (et) | Bitsüklilised guanidiini derivaadid ja nende terapeutiline kasutamine | |
PT1373249E (pt) | Derivados de imidazolidina, sua preparacao e sua utilizacao como agente anti-inflamatorio | |
EE200300466A (et) | Püridoindolooni derivaatide kasutamine ravimite valmistamiseks | |
EE200300563A (et) | Bensüülaminopürimidiiniühendid, nende kasutamine ja ravim | |
GB0007217D0 (en) | Materials and methods relating to the treatment of leukaemias | |
EE200200266A (et) | 2-arüülkinoliini derivaadid, nende valmistamine ja kasutamine ravimites | |
ES1048221Y (es) | Pieza para salvar esquina y arista de peldaño. | |
FI20011835A0 (fi) | Flavonoidikoostumus ja sen valmistus ja käyttö | |
SI1280522T1 (en) | Combination of carboxyalkylethers with antihypertensives and pharmaceutical use |